目的 初步探討生長激素釋放激素受體（GHRHR）在腎上腺腫瘤組織中的表達及其在臨床中的實際應用價值。 方法 應用免疫組織化學方法檢測2001年1月－2009年10月間187例腎上腺腫瘤和20例正常腎上腺組織標本中GHRHR的表達。 結果 腎上腺皮質腫瘤與腎上腺髓質腫瘤、正常腎上腺組織比較，GHRHR表達明顯增高（陽性率分別為99%、45%、55%），GHRHR在腎上腺皮質醇瘤和醛固酮瘤中表達的差異有統計學意義，在腎上腺皮質腺瘤、皮質腺癌、皮質增生中表達的差異有統計學意義。 結論 GHRHR在人正常腎上腺及腎上腺腫瘤組織中的表達，為在垂體外組織及人類腫瘤組織存在GHRHR的表達提供了直接證據；GHRHR可能會用于腎上腺皮質腫瘤和髓質腫瘤的鑒別診斷，但GHRHR尚不能用于良性和惡性腎上腺皮質腫瘤的鑒別診斷。GHRHR在腎上腺皮質相關腫瘤的高表達，可能與腎上腺皮質腫瘤的發病機制有關。
目的 采用已有的4種國際非孕彌散性血管內凝血（DIC）診斷評分標準對產科DIC的診斷進行評估，探索更適合產科DIC診斷的“金標準”。 方法 選擇2009年6月－2012年6月期間產科擬診DIC的孕產婦為研究對象，用日本衛生福利部（JMHW）提出的JMHW、日本危重病協會（JAAM）提出的JAAM、國際血栓與止血委員會（ISTH）提出的ISTH顯性和ISTH非顯性4種診斷評分標準聯合診斷和構建“金標準”，以此評價4種診斷標準對產科DIC診斷的特性。 結果 受試者工作特征（ROC）曲線分析顯示ISTH非顯性標準、ISTH顯性標準、JMHW、JAAM的ROC曲線下面積分別為0.939、0.865、0.867、0.867，ISTH非顯性標準靈敏度和特異度與“金標準”在不同診斷界值時較一致，同時優于其他3種診斷標準。 結論 ISTH非顯性標準較適合作為臨床產科DIC診斷，其對產科這一特殊發病人群的DIC診斷具有更科學的臨床診斷價值。
Objective To introduce growth and differentiation factor 5 (GDF-5) gene into hBMSCs using recombinant adenovirus vector and to investigate the effect of GDF-5 gene expression on hBMSCs osteogenic differentiation. Methods Recombinant adenovirus GDF-5 (Ad-GDF-5) containing green fluorescent protein (GFP) and Ad-GFP were amplifiedand tittered. hBMSCs at passage 3 were infected with two viruses at different titers. At 2 days after intervention, GFP expression was observed using fluorescence microscope, and GDF-5 expression in hBMSCs was detected by RT-PCR. Adherent hBMSCs at passage 3 were randomly divided into 4 groups: experimental group (GDF-5 gene transfection), osteogenic induction group, Ad- GFP infection group, and control group. Cell differentiation was detected by inverted phase contrast microscope observation, fluorescence microscope observation, reverse transcription fluorescence quantitative PCR, immunofluorescence staining, and von Kossa staining at different time points after intervention. Results The titer of Ad-GDF-5 and Ad-GFP was 1.0 × 109 pfu/mL and 1.2 × 109 pfu/mL, respectively. hBMSCs was efficiently infected by Ad-GDF-5 and Ad-GFP, and expressed target gene and GFP gene. At 1-7 days after intervention, morphology and growth pattern of the hBMSCs in the experimental group and the osteogenic induction group were transformed into osteoblast-l ike cells, whereas the cells in the other two groups were still maintained their original morphology and growth pattern. Reverse transcription fluorescence quantitative PCR detection: at 4 days after intervention, GDF-5 expression in the experimental group was obviously higher than that of other groups (P lt; 0.05); ALP, Col I, and OC gene expression in the experimental and the osteogenic induction group were superior to those of theAd-GFP infection and the control group (P lt; 0.05); Col I gene expression in the osteogenic induction group was greater than that of the experimental group (P lt; 0.05). Immunofluorescence staining: at 4 days after intervention, the cells in the osteogenic induction group and the experimental group expressed and secreted Col I, and no expression of Col I was evident in the other two groups. At 10 days after intervention, the cells in the osteogenic induction and the experimental group were positive for von Kossa staining, and the results of the other two groups were negative. Conclusion GDF-5 gene can be transferred into hBMSCs via adenovirus vector and be expressed stably. It can facil itate the osteogenic differentiation of the hBMSCs and lay a foundation for the further study of this kind of gene transferred hBMSCs effect on bone tissue repair.
ObjectiveTo investigate the domestic and abroad hypertension-related clinical trial registration and to analyze the registration of hypertension-related clinical researches in China.MethodsUsing hypertension as the keyword, we searched ClinicalTrials.gov and Chinese Clinical Trial Registry (ChiCTR) from January 2008 to December 2018. We analyzed the collected data on the distribution of registered clinical researches, annual trends, sample sizes, trial progress, research types, study designs, blind methods, clinical stages, the number of participating institutions, the leading institutions, etc.ResultsThe total number of registered hypertension-related clinical trails was 4 991 all over the world, and 551 items were conducted in China. Most of the sample sizes of Chinese hypertension-related clinical trials were 100 to 999. The main types of trials were interventional studies (393 items, 71.32%), followed by observational studies (126 items, 22.87%). Randomized parallel control studies (300 items, 76.34%) were the key component of interventional studies, while cohort studies (61 items, 48.41%) were the chief component of observational studies. The main stages of clinical trials were stage Ⅲ (80 items) and stage Ⅳ (122 items). There were 369 domestic single-center clinical trials (66.97%), 89 domestic multi-center clinical trials (16.15%), and 93 international multi-center clinical trials (16.88%). Among the 93 international multi-center trials of hypertension, only 25 were led by China.ConclusionsThe number of Chinese hypertension-related clinical trial registrations increased year by year and then decreased slightly, but the amount of registrations is limited. The quantity and scale of multicenter clinical studies were not as good as America. China should strengthen the awareness of clinical research registration, strengthen the publicity and supervision of the registration of clinical researches by the department of science and management, improve the number of clinical trial registrations, make Chinese clinical researches more transparent, and strive to lead more international multi-center clinical trials.
Objective To systematically review the rate of sleep deprivation in children and adolescents in China from 2004 to 2019. Methods PubMed, The Cochrane Library, EMbase, Web of Science, CBM, CNKI and WanFang Data databases were searched to collect cross-sectional studies on the sleep deprivation rate of children and adolescents in China from inception to July 15th, 2021. Two researchers independently screened literature, extracted data and evaluated the risk of bias of the included studies. Meta-analysis was then performed by using Stata 15.0 software. Results A total of 45 cross-sectional studies were included, with a total sample size of 769 918 participants, of whom 587 457 reported sleep deprivation. The results of meta-analysis showed that the sleep deprivation rate of Chinese children and adolescents was 61% (95%CI 55% to 68%). Subgroup analysis indicated that the sleep deprivation rates were 62% for female children and 59% for male children. The rate was 84% in junior high school, 80% in high school and 64% in primary school. The rates in south China, southwest China, northwest China, north China, east China and central China were 68%, 62%, 61%, 57%, 57% and 54%, respectively. The rate of sleep deficiency based on "health requirements for daily study time of primary and junior school students" was the highest at 74% (95% CI 70% to 79%). The cumulative meta-analysis by time showed that the sleep deprivation rate had gradually stabilized and approached 60% since 2011. Conclusion Current evidence shows that the sleep deprivation rate of Chinese children and adolescents is high. Due to the limited quality and quantity of included studies, more high-quality studies are needed to verify the above conclusion.
Objective To observe the effect of titanium mesh cage with self-locked titanium plate on the cervicalinter-body fusion after anterior discectomy of multilevel cervical intervertebral disc protrusion. Methods The therapeuticeffect of 18 patients who received the treatment of titanium mesh cage with self-locked titanium plate from September 2004 to June 2007 were retrospectively analyzed, including 11 males and 7 females (aged 32-75 years, 54 years on average). The course of disease was 6 months to 15 years (5.8 years on average). Sixteen patients suffered sensory dysfunction in l imbs. Concerning the muscle strength of extremities, 3 cases were on the second level, 12 were on the third level, 1 was on the fourth level, and 2 were on the fifth level. Sixteen cases had pyramidal sign, 13 had retention of urine and feces, 8 had sexual dysfunction, and 7 combined with symptoms of nerve root type. Twelve cases were consecutive multilevel and 6 cases were discontinuous multilevel. The mean JOA scores were 8.30 ± 1.21 preoperatively. X-ray films and MRI showed degeneration and protrusion of intervertebral disc and compression of cervical cord preoperatively. The height of involved intervertebral space was (6.40 ± 0.87) mm on X-ray films preoperatively. Results All the incisions were healed by first intention. All the patients were followed up for 6-36 months (18 months on average). The recovery of extremities motor function was better than that of sensory function at the early stage after operation. Muscular tension decreased after operation and mobil ity of l imbs was improved. The operated segments were instantly stable and sol id fusion was observed at 3-6 months after operation. JOA scores at 6 months after operation was 12.60 ± 0.78 with an improvement rate of 51.8%, indicating significant difference wasevident when compared with the JOA scores before operation (P lt; 0.05). The height of involved intervertebral space increased significantly to (8.20 ± 0.46) mm postoperatively, indicating the difference was significant (P lt; 0.05). According to Odom’s evaluation scale, 17 patients were graded as excellent and 1 as good. No death and compl ications of spinal cord, nerve, trachea and esophagus were observed. The cage witnessed no translocation. Conclusion Titanium mesh cage with self-locked titanium plate is more stable and effective for the treatment of multilevel cervical intervertebral disc protrusion.
Magnetic resonance imaging (MRI)-based electroencephalography (EEG) forward modeling method has become prevalent in the field of EEG. However, due to the inability to obtain clear images of an infant’s fontanel through MRI, the fontanelle information is often lacking in the EEG forward model, which affects accuracy of modeling in infants. To address this issue, we propose a novel method to achieve fontanel compensation for infant EEG forward modeling method. First, we employed imaging segmentation and meshing to the head MRIs, creating a fontanel-free model. Second, a projection-based surface reconstruction method was proposed, which utilized priori information on fontanel morphology and the fontanel-free head model to reconstruct the two-dimensional measured fontanel into a three-dimensional fontanel model to achieve fontanel-compensation modeling. Finally, we calculated a fontanel compensation-based EEG forward model for infants based on this model. Simulation results, based on a real head model, demonstrated that the compensation of fontanel had a potential to improve EEG forward modeling accuracy, particularly for the sources beneath the fontanel (relative difference measure larger than 0.05). Additional experimental results revealed that the uncertainty of the infant’s skull conductivity had the widest impact range on the neural sources, and the absence of fontanel had the strongest impact on the neural sources below the fontanel. Overall, the proposed fontanel-compensated method showcases the potential to improve the modeling accuracy of EEG forward problem without relying on computed tomography (CT) acquisition, which is more in line with the requirements of practical application scenarios.
The emergence of new-generation artificial intelligence technology has brought numerous innovations to the healthcare field, including telemedicine and intelligent care. However, the artificial intelligent medical device sector still faces significant challenges, such as data privacy protection and algorithm reliability. This study, based on invention patent analysis, revealed the technological innovation trends in the field of artificial intelligent medical devices from aspects such as patent application time trends, hot topics, regional distribution, and innovation players. The results showed that global invention patent applications had remained active, with technological innovations primarily focused on medical image processing, physiological signal processing, surgical robots, brain-computer interfaces, and intelligent physiological parameter monitoring technologies. The United States and China led the world in the number of invention patent applications. Major international medical device giants, such as Philips, Siemens, General Electric, and Medtronic, were at the forefront of global technological innovation, with significant advantages in patent application volumes and international market presence. Chinese universities and research institutes, such as Zhejiang University, Tianjin University, and the Shenzhen Institute of Advanced Technology, had demonstrated notable technological innovation, with a relatively high number of patent applications. However, their overseas market expansion remained limited. This study provides a comprehensive overview of the technological innovation trends in the artificial intelligent medical device field and offers valuable information support for industry development from an informatics perspective.
The rapid development of artificial intelligence technology is driving profound changes in medical practice, particularly in the field of medical device application. Based on data from the U.S. clinical trials registry, this study analyzes the global registration landscape of clinical trials involving artificial intelligence-based medical devices, aiming to provide a reference for their clinical research and application. A total of 2 494 clinical trials related to artificial intelligence medical devices have been registered worldwide, with participation from 66 countries or regions. The United States leads with 908 trials, while for other countries or regions, including China, each has fewer than 300 trials. Germany, the United States, and Belgium serve as central hubs for international collaboration. Among the sponsors, 63.96% are universities or hospitals, 22.36% are enterprises, and the remainder includes individuals, government agencies and others. Of all trials, 79.99% are interventional studies, 94.67% place no restrictions on participant gender, and 69.69% exclude children. The targeted diseases are primarily neurological and mental disorders. This study systematically reveals the global distribution characteristics and research trends of artificial intelligence medical device clinical trials, offering valuable data support and practical insights for advancing international collaboration, resource allocation, and policy development in this field.
This article reviews the current status and characteristics of disinfection technologies in the modern era, including physical, chemical, and integrated disinfection methods. It focuses on the latest research advances, advantages, and limitations of novel disinfection technologies, such as plasma-activated systems, photocatalytic oxidation, and synergistic chemical-physical or bio-chemical composite techniques. The study reveals that single disinfection methods often fail to meet the demands of complex environments, while integrated technologies demonstrate significant advantages in improving disinfection efficiency and environmental compatibility. However, challenges remain in terms of cost, standardization, and long-term safety. Future development of disinfection technologies should prioritize intelligent multi-technology integration, green and sustainable practices, targeted disinfection, personalized applications, and international standardization.